MLB official says Ryan Braun’s 50-game PED suspension is unlikely to be overturned

38 Comments

At some point within the next few weeks, Brewers outfielder Ryan Braun will have the opportunity to plead his innocence against a charge that he was taking performance-enhancing drugs around the start of the 2011 postseason. But he faces great odds.

The evidence against him comes in the form of a test, administered in either late September or early October, that had a positive reading for elevated levels of testosterone. That test was then passed along to the World Anti-Doping Agency lab in Montreal, where it was determined through further examination that the testosterone was synthetic — not produced by Braun’s body.

Braun might argue that the result was a false-positive, but an expert in the field of drug testing told Jeff Passan of Yahoo! Sports last month that those are “almost impossible” with today’s technology. Braun might say that result was triggered by a prescribed medication — something non-performance-enhancing — but how can he prove that and would it really matter if he could? The test showed insanely high levels of unnatural testosterone. However that testosterone arrived in Braun’s system, it’s against the rules for it to be there.

And even if Braun is telling the truth, and has never put synthetic testosterone into his body, a test that boasts an accuracy rating of nearly 100 percent says that the stuff was, at one point, present.

Which leads us to a report from Tom Haudricourt of the Milwaukee Journal Sentinel, who was told this weekend by an “MLB official familiar with the process” that Braun’s 50-game suspension is unlikely to be overturned. The 2011 NL MVP deserves his day in court, and he’ll get it later this month when he presents his case in front of an arbitrator, but it’s nearly certain that he’ll miss close to one-third of the 2012 campaign.

Report: Athletics to acquire Stephen Piscotty from the Cardinals

Scott Kane/Getty Images
1 Comment

Jon Heyman of FanRag Sports reports that the Athletics and Cardinals have agreed on a trade involving outfielder Stephen Piscotty. The Cardinals will receive two as yet unknown minor leaguers in return.

Piscotty, 26, hit .235/.342/.367 with nine home runs and 39 RBI in 401 plate appearances for the Cardinals this past season. He dealt with injuries and with his mother’s ALS diagnosis, so it was a rough year, but very excusably so. The Cardinals had signed him to a six-year, $33.5 million contract extension in March. He’s under contract through 2022 at a total of $29.5 million and has a club option for 2023 worth $15 million with a $1 million buyout.

The Cardinals had an outfield spot open up after agreeing to acquire Marcell Ozuna from the Marlins on Wednesday so the Piscotty trade doesn’t come as a surprise.